Institute of Molecular and Clinical Ophthalmology Basel (IOB)

IOB (Institute of Molecular and Clinical Ophthalmology Basel) is dedicated to advancing the understanding of vision and its diseases, with the ultimate goal of developing innovative therapies for vision loss. Founded in 2017 and operational since 2018, IOB operates as a foundation at the forefront of biotechnology and education. The institute fosters collaboration between basic researchers and clinicians, leveraging their in-depth knowledge of unmet medical needs and daily exposure to patients.

IOB's interdisciplinary teams of researchers and clinicians are committed to accelerating the translation of basic research into groundbreaking treatments that revolutionize ophthalmic therapy. By focusing on the genetic, structural, and functional understanding of cell types and their interactions within the human eye, IOB aims to drive meaningful advancements in the field of ophthalmic disease.

With the slogan "Researchers and Clinicians united to restore vision," IOB embodies a highly collaborative environment where discoveries and technologies are seamlessly transformed into clinical benefits for patients with blinding conditions. This approach ensures that IOB remains at the forefront of advancing the practice of ophthalmology, ultimately striving to enhance the quality of life for individuals affected by vision impairment.